This article is intended for primary care physicians, obstetricians/gynecologists/women's health practitioners, hematologists/oncologists, nurses, and other members of the healthcare team for pregnant women and their offspring.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 8/16/2019
Valid for credit through: 8/16/2020
processing....
Although childhood cancer is relatively rare, it is still the leading cause of death past infancy among children in the United States. Infants and children are especially susceptible to prenatal and early-life exposures. Maternal exposures before and during pregnancy (eg, obesity) could therefore have a significant effect on the health of the child, including a risk for cancer development.
The goal of this registry study by Stacy and colleagues was to evaluate the association of maternal anthropometric characteristics derived from birth certificates with an increased risk for development of cancer in childhood after adjustment for known maternal and infant risk factors.
Obesity has been linked to an increased risk for cancer in adults, but its potential role in childhood cancers is less clear. New findings suggest that infants born to obese mothers are more likely to develop cancer in early childhood.
An analysis of data from almost 2 million infants found that the offspring of women who were severely obese (body mass index [BMI] >40 kg/m2) were twice as likely to develop leukemia before age 5 years than the offspring of women who were of normal weight.
After adjusting for confounders such as maternal age and race, which are 2 established risk factors for childhood cancer, maternal obesity was associated with the risk for childhood cancer.
"Right now, we don't know of many avoidable risk factors for childhood cancer," said lead author Shaina Stacy, PhD, postdoctoral scholar in the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania.
"My hope is that this study can be, in a way, empowering and also motivating for weight loss," she said in a statement.
The study was published online in the American Journal of Epidemiology.
High BMI Linked to Cancer RiskFor the study, Dr Stacy and colleagues used data from the Pennsylvania Department of Health. They identified 1,827,875 infants who were born between 2003 and 2015.
A total of 2352 children were diagnosed with any type of cancer, and 747 children were diagnosed with leukemia before age 14 years.
The most common diagnoses were acute lymphoblastic leukemia (ALL) and neuroblastoma.
Older maternal age was associated with a higher risk for any childhood cancer, including leukemia. Nonwhite race was associated with a lower risk. The analyses were adjusted for these risk factors.
The offspring of women with a BMI ≥40 kg/m2 had a 1.32 times higher risk of developing any type of cancer and 1.57 times higher risk for leukemia compared with children born to mothers with BMIs of 18.5 to 24.9 kg/m2.
In addition, children born to mothers with prepregnancy weights of 90 to 99 kg and ≥100 kg had a 46% and 42% higher risk for leukemia, respectively.
With respect to infant factors, the authors found that those infants whose birth weight was 30% lower than expected or 30% higher than expected had a 37% and a 116% higher risk for any childhood cancer, respectively, as compared with infants who were within 10% of their expected weight (P curvilinearity <.0001).
Infants whose birth weight was ≥30% higher than expected had an 84% higher risk of developing leukemia. Infants who were large for gestational age also had a greater risk for any cancer and leukemia in comparison with infants who were of appropriate size.
"We are dealing with an obesity epidemic in this country," said senior author Jian-Min Yuan, MD, PhD, professor of epidemiology at University of Pittsburgh Public Health and coleader of the Cancer Epidemiology and Prevention Program at UPMC Hillman Cancer Center, in a statement.
"From a prevention point of view, maintaining a healthy weight is not only good for the mother but also for the children, too," he said.
Weighing in on the study, Maria Chang Swartz, PhD, MPH, RD, LD, assistant professor, department of pediatrics-research, The University of Texas MD Anderson Cancer Center, Houston, Texas, noted that, overall, the findings from this study point to an area that needs further investigation.
"I agree that at this time, the biological mechanisms are still unknown," she said. "The authors' conjecture regarding the role of insulin-like growth hormone factor is an area that is receiving a lot of attention, especially given that stronger evidence is showing an association between high prepregnancy BMI and risk for childhood obesity."
Nonetheless, she did not feel there is enough evidence at this time to include a discussion of a risk for childhood leukemia during the prepregnancy consults for women with high BMIs, "[b]ut maintaining a healthy weight is important, because obesity is associated with many health issues," Dr Swartz said. "Given that stronger evidence is showing an association between high prepregnancy BMI and risk for gestational diabetes as well as risk for childhood obesity in their offspring, there is a need to emphasize maintenance of healthy weight among women of childbearing age," she said.
The study was partially supported by the Arnold Palmer Endowment Fund. Stacy was supported by the National Cancer Institute of the National Institutes of Health. The other authors have disclosed no relevant financial relationships.
Am J Epidemiol. Published online May 20, 2019.[1]